GE MEDICAL SYSTEMS

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

First Posted Date
2005-08-04
Last Posted Date
2019-05-31
Lead Sponsor
GE Healthcare
Target Recruit Count
251
Registration Number
NCT00126412
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease

First Posted Date
2005-08-04
Last Posted Date
2016-12-13
Lead Sponsor
GE Healthcare
Target Recruit Count
587
Registration Number
NCT00126425
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease

First Posted Date
2005-08-04
Last Posted Date
2018-03-14
Lead Sponsor
GE Healthcare
Target Recruit Count
515
Registration Number
NCT00126438
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath